What is Zacks Research’s Estimate for Teleflex Q2 Earnings?

Teleflex Incorporated (NYSE:TFX) – Investment analysts at Zacks Research lowered their Q2 2025 earnings estimates for shares of Teleflex in a note issued to investors on Tuesday, June 24th. Zacks Research analyst R. Department now forecasts that the medical technology company will post earnings per share of $3.34 for the quarter, down from their previous estimate of $3.35. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q3 2025 earnings at $3.36 EPS, Q4 2025 earnings at $3.72 EPS, FY2025 earnings at $13.33 EPS, Q3 2026 earnings at $3.78 EPS, Q4 2026 earnings at $3.51 EPS and FY2026 earnings at $13.74 EPS.

TFX has been the subject of several other research reports. Mizuho set a $155.00 price objective on shares of Teleflex in a research note on Wednesday, April 16th. Raymond James Financial cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Wall Street Zen upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday, June 21st. Truist Financial reduced their price objective on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating for the company in a research note on Monday, May 5th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average price target of $164.63.

Teleflex Price Performance

Shares of NYSE:TFX opened at $119.29 on Thursday. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. The company has a market cap of $5.27 billion, a P/E ratio of 37.63, a PEG ratio of 1.88 and a beta of 1.10. Teleflex has a 52 week low of $115.94 and a 52 week high of $249.91. The company has a 50-day moving average price of $124.81 and a 200 day moving average price of $148.76.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The firm’s revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the firm earned $3.21 earnings per share.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were given a $0.34 dividend. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.14%. Teleflex’s dividend payout ratio is presently 42.90%.

Institutional Trading of Teleflex

Several large investors have recently modified their holdings of TFX. CX Institutional purchased a new stake in shares of Teleflex during the first quarter worth about $105,000. QRG Capital Management Inc. grew its holdings in shares of Teleflex by 35.9% during the first quarter. QRG Capital Management Inc. now owns 2,959 shares of the medical technology company’s stock worth $409,000 after buying an additional 781 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Teleflex during the fourth quarter worth about $10,342,000. IFP Advisors Inc grew its holdings in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock worth $55,000 after buying an additional 217 shares in the last quarter. Finally, UMB Bank n.a. grew its holdings in shares of Teleflex by 3,763.6% during the first quarter. UMB Bank n.a. now owns 425 shares of the medical technology company’s stock worth $59,000 after buying an additional 414 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.